AMGN

Amgen

$327.64

+0.33 (+0.1%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 03.01.2026
$325.88
(-0.54%)
Strong Buy: 4
Buy: 10
Hold: 15
Sell: 2
Strong Sell: 1
Description:
Amgen Inc. is a leading multinational biopharmaceutical company headquartered in Thousand Oaks, California, recognized for its pioneering therapies developed through recombinant DNA technology. The company focuses on key therapeutic areas including oncology, nephrology, and inflammation, utilizing its deep expertise in molecular biology to create and commercialize innovative biologic products that significantly improve patient outcomes. With a comprehensive drug pipeline and a strong foothold in the biotechnology landscape, Amgen is dedicated to addressing global unmet medical needs while striving to enhance the quality of life for patients across the globe. Its commitment to research and development positions Amgen as a critical player in advancing medical science and improving health outcomes worldwide.
Exchange:
NASDAQ
Country:
USA
Sector:
HEALTHCARE
Industry:
DRUG MANUFACTURERS - GENERAL
Address:
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, UNITED STATES, 91320-1799
Fiscal year end:
December
Market capitalization:
$176 Billion
EBITDA:
$16.5 Billion
PERatio:
25.31
EPS:
12.93
Dividend per share:
$9.39
Dividend yield:
2.86%
Beta:
0.447

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
+171%
How much will you get:
$2,713
Prices dates:
31-12-2015: $120.65 and 31-12-2025: $327.31